Foot and mouth disease virus transmission among vaccinated pigs after exposure to virus shedding pigs

The aim of this study was to design a transmission experiment that enabled quantification of the effectiveness of vaccination against foot and mouth disease (FMD) virus in groups of pigs. Previous experiments showed that intradermal injection of pigs with FMD virus 14 days after vaccination was not...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 25; no. 34; pp. 6381 - 6391
Main Authors Orsel, K., de Jong, M.C.M., Bouma, A., Stegeman, J.A., Dekker, A.
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 21.08.2007
Elsevier
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The aim of this study was to design a transmission experiment that enabled quantification of the effectiveness of vaccination against foot and mouth disease (FMD) virus in groups of pigs. Previous experiments showed that intradermal injection of pigs with FMD virus 14 days after vaccination was not suitable to start an infection chain, as inoculated vaccinated pigs resisted challenge. Therefore, we carried out two experiments in which we used direct contact to a non-vaccinated pig as route of infection. In the first experiment only the vaccine effect on susceptibility was quantified by exposing pigs, either vaccinated 14 days before or not vaccinated, each to a non-vaccinated seeder pig inoculated with FMD virus O/NET/2001. Since no significant differences were observed between contact infections in vaccinated or non-vaccinated pigs, we performed a second experiment in which both susceptibility and infectivity were subject to vaccination. We quantified virus transmission in homogenous groups of vaccinated or non-vaccinated pigs in which the infection chain was started by exposure to a third group of non-vaccinated infected pigs. Transmission occurred to all contact-exposed pigs in the non-vaccinated groups and to 9 out of 10 contact-exposed pigs in the vaccinated groups. The rate of transmission ( β) was significantly reduced in the vaccine group. Yet, the estimated reproduction ratio in both groups was still above 1. In conclusion, by adjusting our transmission study design and challenge method, we were able to quantify transmission of FMDV among vaccinated pigs. According to this study a single vaccination was not sufficient to stop pig to pig virus transmission. With these results major outbreaks may still be expected, even in groups of vaccinated pigs.
AbstractList The aim of this study was to design a transmission experiment that enabled quantification of the effectiveness of vaccination against foot and mouth disease (FMD) virus in groups of pigs. Previous experiments showed that intradermal injection of pigs with FMD virus 14 days after vaccination was not suitable to start an infection chain, as inoculated vaccinated pigs resisted challenge. Therefore, we carried out two experiments in which we used direct contact to a non-vaccinated pig as route of infection. In the first experiment only the vaccine effect on susceptibility was quantified by exposing pigs, either vaccinated 14 days before or not vaccinated, each to a non-vaccinated seeder pig inoculated with FMD virus O/NET/2001. Since no significant differences were observed between contact infections in vaccinated or non-vaccinated pigs, we performed a second experiment in which both susceptibility and infectivity were subject to vaccination. We quantified virus transmission in homogenous groups of vaccinated or non-vaccinated pigs in which the infection chain was started by exposure to a third group of non-vaccinated infected pigs. Transmission occurred to all contact-exposed pigs in the non-vaccinated groups and to 9 out of 10 contact-exposed pigs in the vaccinated groups. The rate of transmission (ß) was significantly reduced in the vaccine group. Yet, the estimated reproduction ratio in both groups was still above 1. In conclusion, by adjusting our transmission study design and challenge method, we were able to quantify transmission of FMDV among vaccinated pigs. According to this study a single vaccination was not sufficient to stop pig to pig virus transmission. With these results major outbreaks may still be expected, even in groups of vaccinated pigs.
The aim of this study was to design a transmission experiment that enabled quantification of the effectiveness of vaccination against foot and mouth disease (FMD) virus in groups of pigs. Previous experiments showed that intradermal injection of pigs with FMD virus 14 days after vaccination was not suitable to start an infection chain, as inoculated vaccinated pigs resisted challenge. Therefore, we carried out two experiments in which we used direct contact to a non-vaccinated pig as route of infection. In the first experiment only the vaccine effect on susceptibility was quantified by exposing pigs, either vaccinated 14 days before or not vaccinated, each to a non-vaccinated seeder pig inoculated with FMD virus O/NET/2001. Since no significant differences were observed between contact infections in vaccinated or non-vaccinated pigs, we performed a second experiment in which both susceptibility and infectivity were subject to vaccination. We quantified virus transmission in homogenous groups of vaccinated or non-vaccinated pigs in which the infection chain was started by exposure to a third group of non-vaccinated infected pigs. Transmission occurred to all contact-exposed pigs in the non-vaccinated groups and to 9 out of 10 contact-exposed pigs in the vaccinated groups. The rate of transmission (beta) was significantly reduced in the vaccine group. Yet, the estimated reproduction ratio in both groups was still above 1. In conclusion, by adjusting our transmission study design and challenge method, we were able to quantify transmission of FMDV among vaccinated pigs. According to this study a single vaccination was not sufficient to stop pig to pig virus transmission. With these results major outbreaks may still be expected, even in groups of vaccinated pigs.The aim of this study was to design a transmission experiment that enabled quantification of the effectiveness of vaccination against foot and mouth disease (FMD) virus in groups of pigs. Previous experiments showed that intradermal injection of pigs with FMD virus 14 days after vaccination was not suitable to start an infection chain, as inoculated vaccinated pigs resisted challenge. Therefore, we carried out two experiments in which we used direct contact to a non-vaccinated pig as route of infection. In the first experiment only the vaccine effect on susceptibility was quantified by exposing pigs, either vaccinated 14 days before or not vaccinated, each to a non-vaccinated seeder pig inoculated with FMD virus O/NET/2001. Since no significant differences were observed between contact infections in vaccinated or non-vaccinated pigs, we performed a second experiment in which both susceptibility and infectivity were subject to vaccination. We quantified virus transmission in homogenous groups of vaccinated or non-vaccinated pigs in which the infection chain was started by exposure to a third group of non-vaccinated infected pigs. Transmission occurred to all contact-exposed pigs in the non-vaccinated groups and to 9 out of 10 contact-exposed pigs in the vaccinated groups. The rate of transmission (beta) was significantly reduced in the vaccine group. Yet, the estimated reproduction ratio in both groups was still above 1. In conclusion, by adjusting our transmission study design and challenge method, we were able to quantify transmission of FMDV among vaccinated pigs. According to this study a single vaccination was not sufficient to stop pig to pig virus transmission. With these results major outbreaks may still be expected, even in groups of vaccinated pigs.
AbstractThe aim of this study was to design a transmission experiment that enabled quantification of the effectiveness of vaccination against foot and mouth disease (FMD) virus in groups of pigs. Previous experiments showed that intradermal injection of pigs with FMD virus 14 days after vaccination was not suitable to start an infection chain, as inoculated vaccinated pigs resisted challenge. Therefore, we carried out two experiments in which we used direct contact to a non-vaccinated pig as route of infection. In the first experiment only the vaccine effect on susceptibility was quantified by exposing pigs, either vaccinated 14 days before or not vaccinated, each to a non-vaccinated seeder pig inoculated with FMD virus O/NET/2001. Since no significant differences were observed between contact infections in vaccinated or non-vaccinated pigs, we performed a second experiment in which both susceptibility and infectivity were subject to vaccination. We quantified virus transmission in homogenous groups of vaccinated or non-vaccinated pigs in which the infection chain was started by exposure to a third group of non-vaccinated infected pigs. Transmission occurred to all contact-exposed pigs in the non-vaccinated groups and to 9 out of 10 contact-exposed pigs in the vaccinated groups. The rate of transmission ( β) was significantly reduced in the vaccine group. Yet, the estimated reproduction ratio in both groups was still above 1. In conclusion, by adjusting our transmission study design and challenge method, we were able to quantify transmission of FMDV among vaccinated pigs. According to this study a single vaccination was not sufficient to stop pig to pig virus transmission. With these results major outbreaks may still be expected, even in groups of vaccinated pigs.
The aim of this study was to design a transmission experiment that enabled quantification of the effectiveness of vaccination against foot and mouth disease (FMD) virus in groups of pigs. Previous experiments showed that intradermal injection of pigs with FMD virus 14 days after vaccination was not suitable to start an infection chain, as inoculated vaccinated pigs resisted challenge. Therefore, we carried out two experiments in which we used direct contact to a non-vaccinated pig as route of infection. In the first experiment only the vaccine effect on susceptibility was quantified by exposing pigs, either vaccinated 14 days before or not vaccinated, each to a non-vaccinated seeder pig inoculated with FMD virus O/NET/2001. Since no significant differences were observed between contact infections in vaccinated or non-vaccinated pigs, we performed a second experiment in which both susceptibility and infectivity were subject to vaccination. We quantified virus transmission in homogenous groups of vaccinated or non-vaccinated pigs in which the infection chain was started by exposure to a third group of non-vaccinated infected pigs. Transmission occurred to all contact-exposed pigs in the non-vaccinated groups and to 9 out of 10 contact-exposed pigs in the vaccinated groups. The rate of transmission ( β) was significantly reduced in the vaccine group. Yet, the estimated reproduction ratio in both groups was still above 1. In conclusion, by adjusting our transmission study design and challenge method, we were able to quantify transmission of FMDV among vaccinated pigs. According to this study a single vaccination was not sufficient to stop pig to pig virus transmission. With these results major outbreaks may still be expected, even in groups of vaccinated pigs.
The aim of this study was to design a transmission experiment that enabled quantification of the effectiveness of vaccination against foot and mouth disease (FMD) virus in groups of pigs. Previous experiments showed that intradermal injection of pigs with FMD virus 14 days after vaccination was not suitable to start an infection chain, as inoculated vaccinated pigs resisted challenge. Therefore, we carried out two experiments in which we used direct contact to a non-vaccinated pig as route of infection. In the first experiment only the vaccine effect on susceptibility was quantified by exposing pigs, either vaccinated 14 days before or not vaccinated, each to a non-vaccinated seeder pig inoculated with FMD virus O/NET/2001. Since no significant differences were observed between contact infections in vaccinated or non-vaccinated pigs, we performed a second experiment in which both susceptibility and infectivity were subject to vaccination. We quantified virus transmission in homogenous groups of vaccinated or non-vaccinated pigs in which the infection chain was started by exposure to a third group of non-vaccinated infected pigs. Transmission occurred to all contact-exposed pigs in the non-vaccinated groups and to 9 out of 10 contact-exposed pigs in the vaccinated groups. The rate of transmission (β) was significantly reduced in the vaccine group. Yet, the estimated reproduction ratio in both groups was still above 1. In conclusion, by adjusting our transmission study design and challenge method, we were able to quantify transmission of FMDV among vaccinated pigs. According to this study a single vaccination was not sufficient to stop pig to pig virus transmission. With these results major outbreaks may still be expected, even in groups of vaccinated pigs.
The aim of this study was to design a transmission experiment that enabled quantification of the effectiveness of vaccination against foot and mouth disease (FMD) virus in groups of pigs. Previous experiments showed that intradermal injection of pigs with FMD virus 14 days after vaccination was not suitable to start an infection chain, as inoculated vaccinated pigs resisted challenge. Therefore, we carried out two experiments in which we used direct contact to a non-vaccinated pig as route of infection. In the first experiment only the vaccine effect on susceptibility was quantified by exposing pigs, either vaccinated 14 days before or not vaccinated, each to a non-vaccinated seeder pig inoculated with FMD virus O/NET/2001. Since no significant differences were observed between contact infections in vaccinated or non-vaccinated pigs, we performed a second experiment in which both susceptibility and infectivity were subject to vaccination. We quantified virus transmission in homogenous groups of vaccinated or non-vaccinated pigs in which the infection chain was started by exposure to a third group of non-vaccinated infected pigs. Transmission occurred to all contact-exposed pigs in the non-vaccinated groups and to 9 out of 10 contact-exposed pigs in the vaccinated groups. The rate of transmission ( beta ) was significantly reduced in the vaccine group. Yet, the estimated reproduction ratio in both groups was still above 1. In conclusion, by adjusting our transmission study design and challenge method, we were able to quantify transmission of FMDV among vaccinated pigs. According to this study a single vaccination was not sufficient to stop pig to pig virus transmission. With these results major outbreaks may still be expected, even in groups of vaccinated pigs.
Author Dekker, A.
Stegeman, J.A.
Bouma, A.
Orsel, K.
de Jong, M.C.M.
Author_xml – sequence: 1
  givenname: K.
  surname: Orsel
  fullname: Orsel, K.
  email: k.orsel@vet.uu.nl
  organization: Faculty of Veterinary Medicine, Department of Farm Animal Health, Utrecht University, P.O. Box 80.151, 3508 TD Utrecht, The Netherlands
– sequence: 2
  givenname: M.C.M.
  surname: de Jong
  fullname: de Jong, M.C.M.
  organization: Animal Sciences Group, Wageningen University and Research Centre, Wageningen, The Netherlands
– sequence: 3
  givenname: A.
  surname: Bouma
  fullname: Bouma, A.
  organization: Faculty of Veterinary Medicine, Department of Farm Animal Health, Utrecht University, P.O. Box 80.151, 3508 TD Utrecht, The Netherlands
– sequence: 4
  givenname: J.A.
  surname: Stegeman
  fullname: Stegeman, J.A.
  organization: Faculty of Veterinary Medicine, Department of Farm Animal Health, Utrecht University, P.O. Box 80.151, 3508 TD Utrecht, The Netherlands
– sequence: 5
  givenname: A.
  surname: Dekker
  fullname: Dekker, A.
  organization: Central Institute for Animal Disease Control Lelystad (CIDC, Lelystad), Wageningen UR, The Netherlands
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18949547$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/17658199$$D View this record in MEDLINE/PubMed
BookMark eNqNkl-LEzEUxYOsuLvVj6AERN9ab5LJzERRkcVVYcEHFXwLmcydbuo0qclM1_32Zmh1oSD16b78zv13zjk58cEjIY8ZLBiw8sVqsTXWOo8LDlAtoFwAg3vkjNWVmHPJ6hNyBrws5gWD76fkPKUVAEjB1ANyyqpS1kypM4KXIQzU-Jauwzhc09YlNAnp1sUx0SEan9YuJRc8Nevgl3Q31QzY0o1bJmq6ASPFX5uQxoh0CHtpusa2dVkwUQ_J_c70CR_t64x8u3z_9eLj_Orzh08X767mtmR8mAsm0aqCyaISqpSdakTLbFHLhtfKMmF43luorsYCKmFlU9asUcYwUGCZEmJGXu763pgl-jwdvfYmWpd0ME73rokm3uqbMWrfT2UzNkkLWXFgWfx8J97E8HPENOh8ucW-Nx7DmHQeBqJix0EOvFIV4xl8egCuwhh9_oBmUipQ2Z8iU0_21NissdWb6NbTln9MysCzPWCSNX2XTZku-svVqlDTy2ZE7jgbQ0oRuzsE9BQavdL70OgpNBpKnUOTda8OdNYNZsieZ_9df1T9dqfGbOzWYdTJOvQWWxfRDroN7miHNwcdbO-8y6f-wFtMdz_TiWvQX6ZYT6mGCqCs68n21_9u8B8L_AZauQpo
CODEN VACCDE
CitedBy_id crossref_primary_10_1080_14760584_2022_2072302
crossref_primary_10_1186_s13567_015_0156_5
crossref_primary_10_1016_j_njas_2013_05_003
crossref_primary_10_1016_S2095_3119_18_61916_1
crossref_primary_10_1371_journal_pone_0077616
crossref_primary_10_3390_ani13193082
crossref_primary_10_1136_vr_162_23_753
crossref_primary_10_1017_S0950268809002349
crossref_primary_10_1016_j_prevetmed_2010_08_005
crossref_primary_10_1016_j_prevetmed_2008_09_001
crossref_primary_10_1051_vetres_2010017
crossref_primary_10_1126_science_adl3962
crossref_primary_10_1111_j_1865_1682_2007_01012_x
crossref_primary_10_1016_j_vetmic_2007_10_003
crossref_primary_10_1186_1297_9716_42_120
crossref_primary_10_1038_s41598_021_95853_3
crossref_primary_10_1016_j_vaccine_2015_04_045
crossref_primary_10_1155_2018_3497401
crossref_primary_10_1016_j_vaccine_2014_10_064
crossref_primary_10_1016_j_rvsc_2014_01_009
crossref_primary_10_3389_fvets_2023_1070188
crossref_primary_10_1038_s41598_017_17174_8
crossref_primary_10_3109_08820139_2014_938164
crossref_primary_10_1051_vetres_2008051
crossref_primary_10_1111_j_1539_6924_2009_01327_x
crossref_primary_10_1637_8204_010708_Reg_1
crossref_primary_10_1016_j_prevetmed_2013_10_005
crossref_primary_10_1136_vr_d693
crossref_primary_10_1016_j_tvjl_2014_06_020
crossref_primary_10_3389_fvets_2020_540433
crossref_primary_10_1016_j_prevetmed_2012_05_012
crossref_primary_10_3389_fvets_2016_00044
crossref_primary_10_1016_j_vaccine_2010_04_019
crossref_primary_10_3389_fvets_2016_00041
crossref_primary_10_3389_fvets_2020_00513
crossref_primary_10_1371_journal_pone_0185184
crossref_primary_10_3389_fvets_2016_00105
crossref_primary_10_1016_j_vaccine_2018_11_080
crossref_primary_10_3389_fvets_2016_00102
crossref_primary_10_1007_s00253_022_12151_2
crossref_primary_10_1016_j_prevetmed_2011_11_007
crossref_primary_10_3390_pathogens12030435
crossref_primary_10_3390_ani10030455
Cites_doi 10.1016/j.vaccine.2003.11.003
10.1016/0021-9975(81)90089-X
10.1016/S0264-410X(02)00242-6
10.1016/S0021-9975(03)00041-0
10.1017/S0950268801006537
10.1017/S095026880100646X
10.1016/S0166-0934(03)00220-9
10.1017/S0950268801006446
10.1016/S0264-410X(97)86180-4
10.1016/S0034-5288(18)30804-X
10.1053/jcpa.2002.0560
10.1016/0264-410X(94)90229-1
10.1017/S095026880600673X
10.1136/vr.148.19.600
10.1016/j.vaccine.2005.05.014
10.1016/S0167-5877(02)00217-9
10.1016/j.vaccine.2006.07.030
10.1111/j.1439-0450.1979.tb00797.x
10.1111/j.1439-0450.1979.tb00798.x
10.1016/j.vetmic.2003.10.016
10.1128/MMBR.30.3.517-529.1966
ContentType Journal Article
Copyright 2007 Elsevier Ltd
Elsevier Ltd
2007 INIST-CNRS
Copyright Elsevier Limited Aug 21, 2007
Wageningen University & Research
Copyright_xml – notice: 2007 Elsevier Ltd
– notice: Elsevier Ltd
– notice: 2007 INIST-CNRS
– notice: Copyright Elsevier Limited Aug 21, 2007
– notice: Wageningen University & Research
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7RV
7T2
7T5
7U9
7X7
7XB
88C
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9-
K9.
KB0
LK8
M0R
M0S
M0T
M1P
M2O
M7N
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
QVL
DOI 10.1016/j.vaccine.2007.06.010
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Nursing & Allied Health Database
Health and Safety Science Abstracts (Full archive)
Immunology Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Healthcare Administration Database (Alumni)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni Edition)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
AIDS and Cancer Research Abstracts
SciTech Premium Collection
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Biological Science Collection
Consumer Health Database
Health & Medical Collection (Alumni Edition)
Healthcare Administration Database
Medical Database
Research Library
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
NARCIS:Publications
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Health Management (Alumni Edition)
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Research Library
Health & Safety Science Abstracts
ProQuest Public Health
ProQuest Central Basic
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
ProQuest Medical Library
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic


Research Library Prep
AIDS and Cancer Research Abstracts
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Veterinary Medicine
Biology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-2518
EndPage 6391
ExternalDocumentID oai_library_wur_nl_wurpubs_357201
3420815651
17658199
18949547
10_1016_j_vaccine_2007_06_010
S0264410X07006883
1_s2_0_S0264410X07006883
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
29Q
4.4
457
4G.
53G
5RE
5VS
7-5
71M
7RV
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8P~
9JM
AAAJQ
AABNK
AAEDT
AAEDW
AAHBH
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABJNI
ABKYH
ABMAC
ABMZM
ABRWV
ABUWG
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACPRK
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADMUD
ADNMO
ADVLN
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEUYN
AEVXI
AEXOQ
AFJKZ
AFKRA
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGEKW
AGGSO
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AQUVI
ASPBG
AVWKF
AXJTR
AZFZN
AZQEC
BBNVY
BENPR
BHPHI
BKEYQ
BKNYI
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CCPQU
CJTIS
CNWQP
CS3
DWQXO
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
FYUFA
G-2
G-Q
GBLVA
GNUQQ
GUQSH
HCIFZ
HEJ
HLV
HMCUK
HMG
HMK
HMO
HVGLF
HX~
HZ~
IHE
J1W
K9-
KOM
L7B
LK8
LUGTX
LW9
M0R
M0T
M1P
M29
M2O
M41
M7P
MO0
N9A
NAPCQ
O-L
O9-
O9~
OAUVE
OK0
OZT
P-8
P-9
P2P
PC.
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PUEGO
Q38
R2-
ROL
RPZ
SAB
SAE
SCC
SDF
SDG
SDP
SES
SEW
SIN
SNL
SPCBC
SSH
SSI
SSZ
SVS
T5K
UKHRP
UV1
WH7
WOW
WUQ
XPP
Z5R
ZGI
ZXP
~G-
3V.
AACTN
AFCTW
AFKWA
AJOXV
ALIPV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AESVU
AJBFU
EFLBG
LCYCR
QYZTP
AAYXX
ACMHX
ADSLC
AGRNS
AGWPP
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T2
7T5
7U9
7XB
8FK
C1K
H94
K9.
M7N
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
-
0R
1
1P
8P
ABFLS
ABPTK
ACJLH
ADALY
AFRUD
BBAFP
FO
G-
GJ
HX
HZ
K
M
O9
QVL
STF
UNR
ID FETCH-LOGICAL-c612t-315ec9415473965f9b3d1c485b289c13a276539f8e4073c5b681b9aa1090c1933
IEDL.DBID AIKHN
ISSN 0264-410X
IngestDate Tue Jan 05 18:07:23 EST 2021
Fri Jul 11 05:28:58 EDT 2025
Thu Jul 10 23:21:15 EDT 2025
Wed Aug 13 10:40:22 EDT 2025
Thu Apr 03 07:00:22 EDT 2025
Mon Jul 21 09:13:14 EDT 2025
Thu Apr 24 22:56:53 EDT 2025
Tue Jul 01 03:45:01 EDT 2025
Fri Feb 23 02:32:30 EST 2024
Sun Feb 23 10:19:15 EST 2025
Tue Aug 26 16:34:25 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 34
Keywords Pigs
Study design
Foot and mouth disease
Virus excretion
Vaccination
Transmission
Picornaviridae
Vaccine
Infection
Virus
Aphthovirus
Vertebrata
Mammalia
Swine
Viral disease
Dissemination
Artiodactyla
Veterinary
Ungulata
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c612t-315ec9415473965f9b3d1c485b289c13a276539f8e4073c5b681b9aa1090c1933
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 17658199
PQID 1559092644
PQPubID 105530
PageCount 11
ParticipantIDs wageningen_narcis_oai_library_wur_nl_wurpubs_357201
proquest_miscellaneous_68103711
proquest_miscellaneous_20279712
proquest_journals_1559092644
pubmed_primary_17658199
pascalfrancis_primary_18949547
crossref_primary_10_1016_j_vaccine_2007_06_010
crossref_citationtrail_10_1016_j_vaccine_2007_06_010
elsevier_sciencedirect_doi_10_1016_j_vaccine_2007_06_010
elsevier_clinicalkeyesjournals_1_s2_0_S0264410X07006883
elsevier_clinicalkey_doi_10_1016_j_vaccine_2007_06_010
ProviderPackageCode CITATION
AAYXX
QVL
PublicationCentury 2000
PublicationDate 2007-08-21
PublicationDateYYYYMMDD 2007-08-21
PublicationDate_xml – month: 08
  year: 2007
  text: 2007-08-21
  day: 21
PublicationDecade 2000
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: Netherlands
– name: Kidlington
PublicationTitle Vaccine
PublicationTitleAlternate Vaccine
PublicationYear 2007
Publisher Elsevier Ltd
Elsevier
Elsevier Limited
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
– name: Elsevier Limited
References de Leeuw, Tiessink, van Bekkum (bib16) 1979; 26
Alexandersen, Brotherhood, Donaldson (bib21) 2002; 128
Alexandersen, Zhang, Donaldson, Garland (bib5) 2003; 129
Orsel, de Jong, Bouma, Stegeman, Dekker (bib7) 2007; 25
Orsel, Dekker, Bouma, Stegeman, Jong (bib6) 2005; 23
Velthuis, Bouma, Katsma, Nodelijk, de Jong (bib4) 2007; 135
Terpstra (bib14) 1972; 77
Donaldson, Gibson, Oliver, Hamblin, Kitching (bib20) 1987; 43
De Jong, Kimman (bib3) 1994; 12
Eble, Bouma, de Bruin, van Hemert-Kluitenberg, van Oirschot, Dekker (bib9) 2004; 22
Moonen, Boonstra, van der Honing, Leendertse, Jacobs, Dekker (bib12) 2003; 113
de Leeuw, Tiessink, Frenkel (bib15) 1979; 26
Barnett, Cox, Aggarwal, Gerber, McCullough (bib2) 2002; 20
French, Kelly, Jones, Clancy (bib18) 2002; 128
Hughes, Kitching, Woolhouse (bib19) 2002; 127
Bouma, Dekker, de Jong (bib11) 2004; 98
Burrows, Mann, Garland, Greig, Goodridge (bib22) 1981; 91
Bouma, Elbers, Dekker, de Koeijer, Bartels, Vellema (bib10) 2003; 57
Couch, Cate, Douglas, Gerone, Knight (bib17) 1966; 30
Donaldson, Alexandersen (bib8) 2001; 148
Klinkenberg, de Bree, Laevens, de Jong (bib13) 2002; 128
Salt, Barnett, Dani, Williams (bib1) 1998; 16
Hughes (10.1016/j.vaccine.2007.06.010_bib19) 2002; 127
Eble (10.1016/j.vaccine.2007.06.010_bib9) 2004; 22
de Leeuw (10.1016/j.vaccine.2007.06.010_bib15) 1979; 26
Alexandersen (10.1016/j.vaccine.2007.06.010_bib5) 2003; 129
Salt (10.1016/j.vaccine.2007.06.010_bib1) 1998; 16
Moonen (10.1016/j.vaccine.2007.06.010_bib12) 2003; 113
Terpstra (10.1016/j.vaccine.2007.06.010_bib14) 1972; 77
Bouma (10.1016/j.vaccine.2007.06.010_bib11) 2004; 98
Donaldson (10.1016/j.vaccine.2007.06.010_bib20) 1987; 43
Couch (10.1016/j.vaccine.2007.06.010_bib17) 1966; 30
Orsel (10.1016/j.vaccine.2007.06.010_bib6) 2005; 23
Klinkenberg (10.1016/j.vaccine.2007.06.010_bib13) 2002; 128
Orsel (10.1016/j.vaccine.2007.06.010_bib7) 2007; 25
Burrows (10.1016/j.vaccine.2007.06.010_bib22) 1981; 91
Donaldson (10.1016/j.vaccine.2007.06.010_bib8) 2001; 148
Alexandersen (10.1016/j.vaccine.2007.06.010_bib21) 2002; 128
Barnett (10.1016/j.vaccine.2007.06.010_bib2) 2002; 20
De Jong (10.1016/j.vaccine.2007.06.010_bib3) 1994; 12
Velthuis (10.1016/j.vaccine.2007.06.010_bib4) 2007; 135
de Leeuw (10.1016/j.vaccine.2007.06.010_bib16) 1979; 26
Bouma (10.1016/j.vaccine.2007.06.010_bib10) 2003; 57
French (10.1016/j.vaccine.2007.06.010_bib18) 2002; 128
References_xml – volume: 113
  start-page: 35
  year: 2003
  end-page: 41
  ident: bib12
  article-title: Validation of a LightCycler-based reverse transcription polymerase chain reaction for the detection of foot-and-mouth disease virus
  publication-title: J Virol Methods
– volume: 12
  start-page: 761
  year: 1994
  end-page: 766
  ident: bib3
  article-title: Experimental quantification of vaccine-induced reduction in virus transmission
  publication-title: Vaccine
– volume: 135
  start-page: 2002
  year: 2007
  end-page: 2017
  ident: bib4
  article-title: Design and analysis of small-scale transmission experiments with animals
  publication-title: Epidemiol Infect
– volume: 148
  start-page: 600
  year: 2001
  end-page: 602
  ident: bib8
  article-title: Relative resistance of pigs to infection by natural aerosols of FMD virus
  publication-title: Vet Rec
– volume: 91
  start-page: 599
  year: 1981
  end-page: 609
  ident: bib22
  article-title: The pathogenesis of natural and simulated natural foot-and-mouth disease infection in cattle
  publication-title: J Comp Pathol
– volume: 57
  start-page: 155
  year: 2003
  end-page: 166
  ident: bib10
  article-title: The foot-and-mouth disease epidemic in The Netherlands in 2001
  publication-title: Prev Vet Med
– volume: 26
  start-page: 85
  year: 1979
  end-page: 97
  ident: bib15
  article-title: Vaccination of pigs with formaldehyde inactivated aluminium hydroxide foot-and-mouth disease vaccines, potentiated with diethylaminoethyldextran (DEAE-D)
  publication-title: Zentralbl Veterinarmed B
– volume: 25
  start-page: 327
  year: 2007
  end-page: 335
  ident: bib7
  article-title: The effect of vaccination on foot and mouth disease virus transmission among dairy cows
  publication-title: Vaccine
– volume: 128
  start-page: 301
  year: 2002
  end-page: 312
  ident: bib21
  article-title: Natural aerosol transmission of foot-and-mouth disease virus to pigs: minimal infectious dose for strain O1 Lausanne
  publication-title: Epidemiol Infect
– volume: 16
  start-page: 746
  year: 1998
  end-page: 754
  ident: bib1
  article-title: Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission
  publication-title: Vaccine
– volume: 26
  start-page: 98
  year: 1979
  end-page: 109
  ident: bib16
  article-title: The challenge of vaccinated pigs with foot-and-mouth disease virus
  publication-title: Zentralbl Veterinarmed B
– volume: 127
  start-page: 22
  year: 2002
  end-page: 29
  ident: bib19
  article-title: Dose-dependent responses of sheep inoculated intranasally with a type O foot-and-mouth disease virus
  publication-title: J Comp Pathol
– volume: 23
  start-page: 4887
  year: 2005
  end-page: 4894
  ident: bib6
  article-title: Vaccination against foot and mouth disease reduces virus transmission in groups of calves
  publication-title: Vaccine
– volume: 30
  start-page: 517
  year: 1966
  end-page: 529
  ident: bib17
  article-title: Effect of route of inoculation on experimental respiratory viral disease in volunteers and evidence for airborne transmission
  publication-title: Bacteriol Rev
– volume: 20
  start-page: 3197
  year: 2002
  end-page: 3208
  ident: bib2
  article-title: Further studies on the early protective responses of pigs following immunisation with high potency foot and mouth disease vaccine
  publication-title: Vaccine
– volume: 98
  start-page: 29
  year: 2004
  end-page: 36
  ident: bib11
  article-title: No foot-and-mouth disease virus transmission between individually housed calves
  publication-title: Vet Microbiol
– volume: 129
  start-page: 1
  year: 2003
  end-page: 36
  ident: bib5
  article-title: The pathogenesis and diagnosis of foot-and-mouth disease
  publication-title: J Comp Pathol
– volume: 43
  start-page: 339
  year: 1987
  end-page: 346
  ident: bib20
  article-title: Infection of cattle by airborne foot-and-mouth disease virus: minimal doses with O1 and SAT 2 strains
  publication-title: Res Vet Sci
– volume: 22
  start-page: 1372
  year: 2004
  end-page: 1378
  ident: bib9
  article-title: Vaccination of pigs two weeks before infection significantly reduces transmission of foot-and-mouth disease virus
  publication-title: Vaccine
– volume: 128
  start-page: 293
  year: 2002
  end-page: 299
  ident: bib13
  article-title: Within- and between-pen transmission of Classical Swine Fever Virus: a new method to estimate the basic reproduction ratio from transmission experiments
  publication-title: Epidemiol Infect
– volume: 77
  start-page: 859
  year: 1972
  end-page: 874
  ident: bib14
  article-title: Pathogenesis of foot-and-mouth disease in experimentally infected pigs
  publication-title: Bull Off Int Epizoot
– volume: 128
  start-page: 325
  year: 2002
  end-page: 332
  ident: bib18
  article-title: Dose–response relationships for foot and mouth disease in cattle and sheep
  publication-title: Epidemiol Infect
– volume: 22
  start-page: 1372
  issue: 11–12
  year: 2004
  ident: 10.1016/j.vaccine.2007.06.010_bib9
  article-title: Vaccination of pigs two weeks before infection significantly reduces transmission of foot-and-mouth disease virus
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2003.11.003
– volume: 91
  start-page: 599
  issue: 4
  year: 1981
  ident: 10.1016/j.vaccine.2007.06.010_bib22
  article-title: The pathogenesis of natural and simulated natural foot-and-mouth disease infection in cattle
  publication-title: J Comp Pathol
  doi: 10.1016/0021-9975(81)90089-X
– volume: 77
  start-page: 859
  issue: 5
  year: 1972
  ident: 10.1016/j.vaccine.2007.06.010_bib14
  article-title: Pathogenesis of foot-and-mouth disease in experimentally infected pigs
  publication-title: Bull Off Int Epizoot
– volume: 20
  start-page: 3197
  issue: 25–26
  year: 2002
  ident: 10.1016/j.vaccine.2007.06.010_bib2
  article-title: Further studies on the early protective responses of pigs following immunisation with high potency foot and mouth disease vaccine
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(02)00242-6
– volume: 129
  start-page: 1
  issue: 1
  year: 2003
  ident: 10.1016/j.vaccine.2007.06.010_bib5
  article-title: The pathogenesis and diagnosis of foot-and-mouth disease
  publication-title: J Comp Pathol
  doi: 10.1016/S0021-9975(03)00041-0
– volume: 128
  start-page: 293
  issue: 2
  year: 2002
  ident: 10.1016/j.vaccine.2007.06.010_bib13
  article-title: Within- and between-pen transmission of Classical Swine Fever Virus: a new method to estimate the basic reproduction ratio from transmission experiments
  publication-title: Epidemiol Infect
  doi: 10.1017/S0950268801006537
– volume: 128
  start-page: 301
  issue: 2
  year: 2002
  ident: 10.1016/j.vaccine.2007.06.010_bib21
  article-title: Natural aerosol transmission of foot-and-mouth disease virus to pigs: minimal infectious dose for strain O1 Lausanne
  publication-title: Epidemiol Infect
  doi: 10.1017/S095026880100646X
– volume: 113
  start-page: 35
  issue: 1
  year: 2003
  ident: 10.1016/j.vaccine.2007.06.010_bib12
  article-title: Validation of a LightCycler-based reverse transcription polymerase chain reaction for the detection of foot-and-mouth disease virus
  publication-title: J Virol Methods
  doi: 10.1016/S0166-0934(03)00220-9
– volume: 128
  start-page: 325
  issue: 2
  year: 2002
  ident: 10.1016/j.vaccine.2007.06.010_bib18
  article-title: Dose–response relationships for foot and mouth disease in cattle and sheep
  publication-title: Epidemiol Infect
  doi: 10.1017/S0950268801006446
– volume: 16
  start-page: 746
  issue: 7
  year: 1998
  ident: 10.1016/j.vaccine.2007.06.010_bib1
  article-title: Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(97)86180-4
– volume: 43
  start-page: 339
  issue: 3
  year: 1987
  ident: 10.1016/j.vaccine.2007.06.010_bib20
  article-title: Infection of cattle by airborne foot-and-mouth disease virus: minimal doses with O1 and SAT 2 strains
  publication-title: Res Vet Sci
  doi: 10.1016/S0034-5288(18)30804-X
– volume: 127
  start-page: 22
  issue: 1
  year: 2002
  ident: 10.1016/j.vaccine.2007.06.010_bib19
  article-title: Dose-dependent responses of sheep inoculated intranasally with a type O foot-and-mouth disease virus
  publication-title: J Comp Pathol
  doi: 10.1053/jcpa.2002.0560
– volume: 12
  start-page: 761
  issue: 8
  year: 1994
  ident: 10.1016/j.vaccine.2007.06.010_bib3
  article-title: Experimental quantification of vaccine-induced reduction in virus transmission
  publication-title: Vaccine
  doi: 10.1016/0264-410X(94)90229-1
– volume: 135
  start-page: 2002
  issue: 2
  year: 2007
  ident: 10.1016/j.vaccine.2007.06.010_bib4
  article-title: Design and analysis of small-scale transmission experiments with animals
  publication-title: Epidemiol Infect
  doi: 10.1017/S095026880600673X
– volume: 148
  start-page: 600
  issue: 19
  year: 2001
  ident: 10.1016/j.vaccine.2007.06.010_bib8
  article-title: Relative resistance of pigs to infection by natural aerosols of FMD virus
  publication-title: Vet Rec
  doi: 10.1136/vr.148.19.600
– volume: 23
  start-page: 4887
  issue: 41
  year: 2005
  ident: 10.1016/j.vaccine.2007.06.010_bib6
  article-title: Vaccination against foot and mouth disease reduces virus transmission in groups of calves
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2005.05.014
– volume: 57
  start-page: 155
  issue: 3
  year: 2003
  ident: 10.1016/j.vaccine.2007.06.010_bib10
  article-title: The foot-and-mouth disease epidemic in The Netherlands in 2001
  publication-title: Prev Vet Med
  doi: 10.1016/S0167-5877(02)00217-9
– volume: 25
  start-page: 327
  year: 2007
  ident: 10.1016/j.vaccine.2007.06.010_bib7
  article-title: The effect of vaccination on foot and mouth disease virus transmission among dairy cows
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2006.07.030
– volume: 26
  start-page: 85
  issue: 2
  year: 1979
  ident: 10.1016/j.vaccine.2007.06.010_bib15
  article-title: Vaccination of pigs with formaldehyde inactivated aluminium hydroxide foot-and-mouth disease vaccines, potentiated with diethylaminoethyldextran (DEAE-D)
  publication-title: Zentralbl Veterinarmed B
  doi: 10.1111/j.1439-0450.1979.tb00797.x
– volume: 26
  start-page: 98
  issue: 2
  year: 1979
  ident: 10.1016/j.vaccine.2007.06.010_bib16
  article-title: The challenge of vaccinated pigs with foot-and-mouth disease virus
  publication-title: Zentralbl Veterinarmed B
  doi: 10.1111/j.1439-0450.1979.tb00798.x
– volume: 98
  start-page: 29
  issue: 1
  year: 2004
  ident: 10.1016/j.vaccine.2007.06.010_bib11
  article-title: No foot-and-mouth disease virus transmission between individually housed calves
  publication-title: Vet Microbiol
  doi: 10.1016/j.vetmic.2003.10.016
– volume: 30
  start-page: 517
  issue: 3
  year: 1966
  ident: 10.1016/j.vaccine.2007.06.010_bib17
  article-title: Effect of route of inoculation on experimental respiratory viral disease in volunteers and evidence for airborne transmission
  publication-title: Bacteriol Rev
  doi: 10.1128/MMBR.30.3.517-529.1966
SSID ssj0005319
Score 2.0949776
Snippet The aim of this study was to design a transmission experiment that enabled quantification of the effectiveness of vaccination against foot and mouth disease...
AbstractThe aim of this study was to design a transmission experiment that enabled quantification of the effectiveness of vaccination against foot and mouth...
SourceID wageningen
proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 6381
SubjectTerms Allergy and Immunology
Animal vaccines
Animals
Applied microbiology
Biological and medical sciences
calves
cattle
Disease transmission
Experiments
Foot & mouth disease
Foot and mouth disease
Foot-and-Mouth Disease - transmission
Foot-and-mouth disease virus
Foot-and-Mouth Disease Virus - immunology
Fundamental and applied biological sciences. Psychology
Hogs
Immunization
infection
Infections
Microbiology
Miscellaneous
Pigs
reduction
responses
sheep
Study design
Swine
Swine Diseases - transmission
Transmission
Vaccination
Vaccines
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
Viral Vaccines - immunology
Virology
Virus excretion
Virus Shedding
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9NAEB5BEagIIQgvQyl7QD3Vqe31a08IIaIKqagSLcpttd6sVapim6zT0n_PjL2OQQqUUw7xxJt9zHw7rw_gbYwoOlcq8E2UFH4cqshXgS78yKSFEGgvRcc8d_Q5PTyNP82TuXO4WZdWOejETlEvak0-8gMKnwWCzPe75odPrFEUXXUUGrfhDrUuo5SubJ6NKR68I_bAa0aMwwjmYwXPwfn0UmkKXbsuhuk0oCLazbbpQaMszljZU11swqL3YfsKz3_VFUT9ZqBmj-ChQ5bsfb8VHsMtU03gbs81eT2Be0cuij6BveO-X_X1PjsZy6_sPttjx2Mna5SZfKVkma5ilw3iT8DM6rplqlqw78S_x1yMh11-W64sa8n44eYhLxzrqIxYPwcIaheswQllHS85Mz-bmtyTrK2dqD0zCzKl3VNP4XT28eTDoe_YGnyNKKlFZZ4YLRAPxLjAaVKKgi9CHedJgXc6HXIVZdQGt8wN3iG5TooUEbNQijJDNcJI_gy2qroyL4Dxskij3ERZkfA4QoxaIMgISlXqSCijMg_iYZ2kdq3MiVHjQg45a-fSLS_RbGaScvfCwIPpWqzpe3ncJJAOm0AOhaqoWiVam5sEs02CxjoFYWUobSQD-SXoAGkwR81L9D_cg3wt6TBQj23-56W7f-zT8T_mAq_BMU7bzrBx5TiQ9bny4M36a9wmFDhSlalXVpKDTGRh9PcnqKsdz8LQg-f9gRhfjquOqFN4wMcTIisiyrKSeps7b6W8Wi1ldUEf-AtW8iRDbPry30N-Bdu9rx21fbgDW-1yZV4jSGyL3U4T_AKTJWcZ
  priority: 102
  providerName: ProQuest
Title Foot and mouth disease virus transmission among vaccinated pigs after exposure to virus shedding pigs
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0264410X07006883
https://www.clinicalkey.es/playcontent/1-s2.0-S0264410X07006883
https://dx.doi.org/10.1016/j.vaccine.2007.06.010
https://www.ncbi.nlm.nih.gov/pubmed/17658199
https://www.proquest.com/docview/1559092644
https://www.proquest.com/docview/20279712
https://www.proquest.com/docview/68103711
http://www.narcis.nl/publication/RecordID/oai:library.wur.nl:wurpubs%2F357201
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED_tQ6AhhKAMKIzhB7SnpU3ifPlxVKsKaNUEG-qb5aQOdBpJ1aQbe-Fv5y5xGiaKhnhJqtbXJPbl7mf77n4Abz1E0ZFStqVdP7Y8R7mWspPYcnUQC4H-UlTMcyfjYHTufZj4kw0YNLkwFFZpbH9t0ytrbb7pm97sz2ez_me78uX2BJWWmFP4Jmy7XASo2ttH7z-Oxm2kB6_4Pai9RQJtIk__onelEtrBNsUMg55NubTrXdTDuSqw49Ka8WIdJH0AO9doBrIqL-o3PzV8DI8MwGRH9TM8gQ2ddeBeTTl504H7J2YzvQMHp3XZ6ptDdtZmYRWH7ICdtgWtUabzhWJmqsRd1og_BT3M85KpbMq-Ew0fM1s97Gq2WBasJB-IOkSLcaxiNGJ1HyC2nbL57GvBKnpypn_Mc1qlZGVuRItvekoetWq1C-fD47PByDKkDVaCYKlEm-7rRCAs8HCcAz8VMZ86iRf5MU7tEocrN6RquGmkcSrJEz8OEDgLpShANEE0yZ_BVpZn-gUwnsaBG2k3jH3uuQhVY8QadqrSxBVKq7ALXjNOMjEVzYlY41I2oWsX0gwvsW2GkkL4HLsLvZXYvC7pcZdA0CiBbPJV0cJKdDp3CYbrBHVh7EQhHVm40pZ_6HIXopXkrdfhXy66f0tP22eMBM6GPey2vUZxZXsjOLO0Bd1FF96sfkY1of0jlel8WUhaJxOh4_69BRW346HjdOF5_UK0F8dRR_ApusDbN0RmxJdVSCpxbhYt5fVyIbNLOuE_FJL7IULUl__fHa9gp16OR4fg7MFWuVjq14gjy3gfNns_HTyGkxCP0QA_15YDz--Ox6effgEH_3bf
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVEARQhBehtLuAXqqU78fB4R4NEppE0WQotyWtbMWVMUOsdOQP8VvZMZexyAFyqWnHOKx157ZmW92d-YDeO4gig6EMHRpuZHumMLShRFHuiW9KAwxXoYl81x_4PVOnfdjd7wBP-taGDpWWfvE0lFPspjWyA9o-8wIKXy_mn7XiTWKdldrCo3KLI7lcoEpW_7y6B3q94VldQ9Hb3u6YhXQY4zmBTodV8Yhxi0HB-K5SRjZEzN2AjfC3CM2bWH51K41CSTmOnbsRh4iu1AIOsEYI9yx8b7XYNOxMZVpweabw8HwQ3OoxC6pRDCxcfDFjXFTM3Rw1rkQMW2Wq76JXsegst310fD2VOSoo6Qi11iHfm_B1gI9TlqWYP0WErt34Y7Csux1ZXz3YEOmbbhesVsu23Cjr_bt27A3rDpkL_fZqCn4yvfZHhs2vbNRpv2JjueUNcKsFr8PsptlBRPphH0jxj-mdpXYxdfZPGcFhVs0V1r3YyV5Equ-AcLoCZuiClnJhM7kj2lGC6KsyJRo_kVOKHiXVz2A0yvR5ENopVkqHwOzk8izAmn5kWs7FqLiCGGNkYgktkIhha-BU-uJx6p5OnF4nPP6lNwZV-olYk-f02lB09CgsxKbVt1DLhPwaiPgdWksOnOO8e0yQX-doMyVS8q5yXOLG_yjUUJgY4y-ngiHbA2ClaRCXRWa-p-H7vxhp807BiEm3g5-tu3acHkzkNVM1mB39TeaCW1ViVRm85zTklzom9bfr6A-erZvmho8qiZE83DUOuLcUAO7mSE8JWqunFM3dbU-yhfzGU_P6QfvkHPb9RENP_n3kHfhZm_UP-EnR4Pjp7BVrfRjrDG3oVXM5vIZQtQi2lF-gcHnq3ZFvwB8fqKQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIqoihCC8DKXdA_RUJ_auH_EBIUSJWkqrSLQot2XtrAVVsUPsNOSv8euYsdcxSIFy6SmHePzYmZ35dndmPoAXHqLovlKOrbkf256ruK2cJLa5DuIowngZVcxzxyfBwZn3fuSP1uBnUwtDaZWNT6wc9ThPaI-8R8dnTkThu5eatIjh_uD15LtNDFJ00trQadQmcqQXc1y-Fa8O91HXLzkfvDt9e2AbhgE7wcheogPydRJhDPPwpQI_jWIxdhOv78e4DklcoXhIrVvTvsZ1j0j8OECUFylF2YwJQh-B970BN0PhuzTHwlHYppeIilQElzgeDoEzaquHeufdS5XQsbnpoBh0HSrgXR0X70xUgdpKa5qNVTj4NmzO0fdkVTHWb8FxcA_uGlTL3tRmeB_WdNaBWzXP5aIDG8fmBL8Du8O6V_Zij522pV_FHttlw7aLNsp0PlGiTlUtzBrxB6AHeV4ylY3ZN-L-Y-Z8iV1-nc4KVlLgRcOlHUBW0SixegwQUI_ZBBXIKk50pn9MctoaZWVuRIsvekxhvLrqIZxdix4fwXqWZ_oJMJHGAe9rHsa-8Dji4xgBjpOqNOGR0iq0wGv0JBPTRp3YPC5kky93Lo16ieIzlJQ36DoWdJdik7qPyFUCQWMEsimSRbcuMdJdJRiuEtSFcU6FdGXBpSM_OhUYdkbo9Yl6SFjQX0oa_FXjqv956PYfdtp-Yz_CJbiHw7bVGK5sX2Q5py3YWf6NZkKHVirT-ayQtDkXhS7_-xXUUU-ErmvB43pCtA9HrSPijSwQ7QyRGZF0FZL6qpudUjmfTWV2QT94h0IKP0Rc_PTfr7wDG-iA5IfDk6NnsFlv-WPQcbdgvZzO9HPEqmW8XTkFBp-v2wv9AjTppWA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Foot+and+mouth+disease+virus+transmission+among+vaccinated+pigs+after+exposure+to+virus+shedding+pigs&rft.jtitle=Vaccine&rft.au=Orsel%2C+K&rft.au=Jong%2C+M.C.M.%2C+de&rft.au=Bouma%2C+A&rft.au=Stegeman%2C+J.A&rft.date=2007-08-21&rft.issn=0264-410X&rft.eissn=1873-2518&rft.volume=25&rft.issue=34&rft_id=info:doi/10.1016%2Fj.vaccine.2007.06.010&rft.externalDBID=n%2Fa&rft.externalDocID=oai_library_wur_nl_wurpubs_357201
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0264410X%2FS0264410X07X04304%2Fcov150h.gif